Alpha9 Theranostics vs Caris Life Sciences
Alpha9 Theranostics vs Caris Life Sciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alpha9 Theranostics is on 44/100 and Caris Life Sciences on 59/100.
Where each one leads
Alpha9 Theranostics
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 44/100
- agent readiness: 47/100 against 22/100
- funding raised: $700M against $10.0M
At a glance
| Measure | Alpha9 Theranostics | Caris Life Sciences |
|---|---|---|
| What it is | Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2017 | 2008 |
| Headquarters | Vancouver, Canada | Irving, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Alpha9 Theranostics | Caris Life Sciences |
|---|---|---|
| Employees | Not published | 1,659 |
| Total funding | $10.0M | $700M |
| Latest round | Seed | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | Not published | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alpha9 Theranostics | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 59/100 |
| Traction | 35/100 | 60/100 |
| Team | 60/100 | Not published |
| Community | 15/100 | Not published |
| Search visibility | 12/100 | 22/100 |
| Quality | 50/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | Not published | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alpha9 Theranostics | Caris Life Sciences |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Analytics | Not detected | Google Tag Manager |
Alpha9 Theranostics vs Caris Life Sciences: common questions
Which is better, Alpha9 Theranostics or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Alpha9 Theranostics and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 44/100), agent readiness (47/100 against 22/100), funding raised ($700M against $10.0M).
Read the full Alpha9 Theranostics review and pricing or the Caris Life Sciences review and pricing. You can also browse other Alpha9 Theranostics alternatives we track.